Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Foot fossil discovery could reshape human evolutionary history - 2Flu season is underway. What are common symptoms to watch for?
- 3Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- 4Key Little Things That Advantage Old People
- 5Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet
- Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- Cygnus XL brings cargo to the ISS for 1st time | Space photo of the day for Dec. 1, 2025
- Astronomers may have spotted the 1st known 'superkilonova' double star explosion
- Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- How to avoid or deal with an outrageous medical bill
- Multi-million-euro win in Spanish lottery in doubt due to oversight
- 'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran
- CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
- Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
